Hematology Instruments and Reagents: A Global Strategic Business Report
San Jose, CA (Vocus/PRWEB) January 17, 2011
Hematology instruments and reagents are indispensable diagnostic tools, and continue to maintain strong position in the global healthcare industry. Over the years, hematology instruments have evolved from simple manual red blood cell counters to sophisticated automated analyzers, which is resulting in better adoption rates. Presently, automated hematology systems play a vital role in transfusion medicine, facilitate screening of blood donors as well as quality control of blood products. The recent years also witnessed the emergence of novel tests for CHr, CSF, CD61, and CD64. Tests for T4 and T8 are also on the horizon. However, global hematology market is assessed as mature and is characterized by intense competition among major companies. Capital replacement cycle controls the market, while introduction of automation such as working cell slide maker stainers increases the replacement of existing equipment, thereby leading to market growth.
Manufacturers are developing analytical automation systems that simplify the testing process, reduce manual work, and further increase the efficacy and productivity of laboratories. As the product purchasing cycles are lengthy in instrumentation market, manufacturers are offering highly accurate and reliable systems that streamline laboratory workflow, reduce error detection problems, and minimize information management concerns.
Hematology analyzers represents the leading segment within the hematology/coagulation instruments market, as stated by the new market research report on Hematology Instruments and Reagents. Present day hematology analyzers are technologically advanced, as compared to the traditional systems that were developed twenty years back. Companies are investing large amounts on product developments, and are offering more sophisticated, user friendly, accurate, and efficient systems that meet the requirements of hospital and clinical laboratories. Moreover, laboratories make purchase decision depending on varied features, including simplified workflow, along with testing automation, higher throughput, flexibility, reliability, enhanced data management, reduced sample volumes, and enhanced sensitivity. User-friendly systems, with advanced capabilities to test additional bodily fluids, and testing methodology specifications are also highly preferred.
The United States leads the global hematology/coagulation instruments and reagents market. Replacement demand for hematology analyzers in the US has been largely hit by laboratory consolidation and increase in the number of group purchasing organizations. Besides this, testing volumes have contracted due to imposition of new standards. The US healthcare market had earlier witnessed a surge in the number of physician office laboratories where physicians conduct in-house tests. However, due to strict adherence to regulatory guidelines, number of such laboratories has dropped subsequently which resulted in reduced demand for low volume analyzers. Growth in demand for hematology instruments and reagents is expected to emanate from Asia-Pacific, Latin America, and other emerging markets.
Flow cytometry techniques are widely prevalent in advanced world. However, opportunities exist in developing countries where cytometry and image analysis are still emerging. Flow cytometers are mainly employed to separate B-cells from T-cell populations, for immunological research applications, for HIV infection detection, for discovering solid tumors, and to aid leukemia and lymphoma phenotyping. These applications are, however, expected to grow in future as more clinical laboratories and hospitals adopt these techniques. Moreover, flow cytometry is also finding new applications in the fields of sperm analysis and microsphere characterization.
Major players profiled in the report include Abbott Diagnostics Inc., Beckman Coulter Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Diagnostica Stago, Horiba Ltd., ImmucorGamma, Instrumentation Laboratory Inc., Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Sysmex Corp., among others.
The research report titled "Hematology Instruments and Reagents: A Global Strategic Business Report" announced by Global Industry Analysts Inc., provides a comprehensive review of the Hematology Instruments and Reagents market, current market trends, key growth drivers, new product innovations/launches, recent industry activity, and profiles of major/niche global market participants. The report provides annual sales estimates and projections for the global Hematology Instruments and Reagents market for the years 2007 through 2015 for the regions, including US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Key segments analyzed include Hematology/Coagulation Instruments (Hematology Analyzers, Hematology Flow Cytometers, Coagulation Analyzers, Hemoglobinometers, Slide Stainers, Hematology Centrifuges, and Hematology Vials), and Hematology/Coagulation Reagents (Flow Cytometry Reagents, Coagulation Reagents, Hematology Reagents, Immuno-Hematology Reagents, Control Plasmas, and Hematology Stains).
For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Hematology_Instruments_And_Reagents_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/
# # #